ProfileGDS4718 / 1565674_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 37% 34% 32% 31% 34% 31% 36% 32% 31% 32% 34% 36% 42% 37% 39% 32% 36% 36% 42% 36% 33% 35% 30% 34% 35% 35% 27% 33% 29% 36% 38% 39% 33% 28% 38% 35% 34% 38% 35% 33% 28% 34% 36% 35% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]4.8586637
GSM549102patient 115, normal, homogenized [OPG study]4.7261434
GSM549104patient 119, normal, homogenized [OPG study]4.6205832
GSM549108patient 138, normal, homogenized [OPG study]4.6328731
GSM549119patient 077, normal, homogenized [OPG study]4.7125534
GSM549133patient 032, cancer, homogenized [OPG study]4.5167531
GSM549139patient 042, cancer, homogenized [OPG study]4.7841736
GSM549099patient 107, normal, homogenized [OPG study]4.6651932
GSM549109patient 139, normal, homogenized [OPG study]4.6246231
GSM549110patient 046, normal, homogenized [OPG study]4.6355932
GSM549114patient 063, normal, homogenized [OPG study]4.6566434
GSM549122patient 082, normal, homogenized [OPG study]4.8125436
GSM549134patient 033, cancer, homogenized [OPG study]5.0830542
GSM549136patient 036, cancer, homogenized [OPG study]4.7867237
GSM549140patient 044, cancer, homogenized [OPG study]4.8890839
GSM549111patient 047, normal, homogenized [OPG study]4.6029532
GSM549113patient 057, normal, homogenized [OPG study]4.7545636
GSM549132patient 031, cancer, homogenized [OPG study]4.7786136
GSM549137patient 038, cancer, homogenized [OPG study]5.0782342
GSM549142patient 047, cancer, homogenized [OPG study]4.9460636
GSM549100patient 110, normal, homogenized [OPG study]4.6808933
GSM549107patient 135, normal, homogenized [OPG study]4.7359135
GSM549115patient 068, normal, homogenized [OPG study]4.4746530
GSM549116patient 072, normal, homogenized [OPG study]4.6871534
GSM549120patient 078, normal, homogenized [OPG study]4.7719235
GSM549131patient 030, cancer, homogenized [OPG study]4.7066335
GSM549118patient 074, normal, homogenized [OPG study]4.4032327
GSM549129patient 027, cancer, homogenized [OPG study]4.7067933
GSM549123patient 088, normal, homogenized [OPG study]4.5028529
GSM549124patient 006, cancer, homogenized [OPG study]4.851336
GSM549126patient 015, cancer, homogenized [OPG study]4.8996238
GSM549128patient 025, cancer, homogenized [OPG study]4.9390239
GSM549103patient 117, normal, homogenized [OPG study]4.7360133
GSM549117patient 073, normal, homogenized [OPG study]4.4327428
GSM549138patient 041, cancer, homogenized [OPG study]4.8760638
GSM549141patient 045, cancer, homogenized [OPG study]4.7015635
GSM549130patient 028, cancer, homogenized [OPG study]4.744834
GSM549101patient 111, normal, homogenized [OPG study]4.9272738
GSM549105patient 128, normal, homogenized [OPG study]4.7620735
GSM549106patient 134, normal, homogenized [OPG study]4.6074733
GSM549112patient 048, normal, homogenized [OPG study]4.439928
GSM549125patient 011, cancer, homogenized [OPG study]4.7129334
GSM549127patient 024, cancer, homogenized [OPG study]4.8019536
GSM549135patient 035, cancer, homogenized [OPG study]4.6855735